Inhibitory Effect of Epigallocatechin 3-O-Gallate on Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 2, 2004, Pages 200-208

  Zheng, Ying ^a   Song, Hye Jin ^a   Kim, Chan Hyung ^a   Kim, Hun Sik ^a   Kim, Eung Gook ^a   Sachinidis, Agapios ^b   Ahn, Hee Yul ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

EGCG; Hypertrophy; JNK; VSMC

Indexed keywords

ANGIOTENSIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; LEUCINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NATURAL PRODUCT; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ADOLESCENT; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; GENE EXPRESSION; HYPERTENSION; MALE; MUSCLE HYPERTROPHY; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; RESTENOSIS; SIGNAL TRANSDUCTION; TEA; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE HYPERTROPHY;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CATECHIN; CELLS, CULTURED; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 1642500105     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200402000-00006     Document Type: Article

References (41)

1. Yamane T, Takahashi T, Kuwata K, et al. Inhibition of N-methyl-N′-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res. 1995;55:2081-2084.
2. Benelli R, Vene R, Bisacchi D, et al. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem. 2002;383:101-105.
3. Santana-Rios G, Orner GA, Amantana A, et al. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res. 2001;495:61-74.
4. Nagai K, Jiang MH, Hada J, et al. (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant. Brain Res. 2002;956:319-322.
5. Yamaguchi K, Honda M, Ikigai H, et al. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 2002;53:19-34.
6. Weisburger JH, Chung FL. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem Toxicol. 2002;40:1145-1154.
7. Nakajima M, Hutchinson HG, Fujinaga M, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92: 10663-10667.
8. Berk BC, Vekshtein V, Gordon HM, et al. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
9. Kyaw M, Yoshizumi M, Tsuchiya K, et al. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res. 2001;24:251-261.
10. Viedt C, Soto U, Krieger-Brauer HI, et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol. 2000;20:940-948.
11. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
12. Ushio-Fukai M, Alexander RW, Akers M, et al. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022-15029.
13. Rivera VM, Greenberg ME. Growth factor-induced gene expression: the ups and downs of c-fos regulation. New Biol. 1990;2:751-758.
14. McKay S, de Jongste JC, Saxena PR, et al. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-betal. Am J Respir Cell Mol Biol. 1998;18:823-833.
15. Kallunki T, Deng T, Hibi M, et al. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 1996;87: 929-939.
16. Pulverer BJ, Kyriakis JM, Avruch J, et al. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991;353:670-674.
17. Chen W, Dong Z, Valcic S, et al. Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog. 1999;24:79-84.
18. Singh R, Ahmed S, Malemud CJ, et al. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J Orthop Res. 2003;21:102-109.
19. Balasubramanian S, Efimova T, Eckert RL. Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. J Biol Chem. 2002;277:1828-1836.
20. Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta. 1997;1333:F85-104.
21. Berk BC, Vekshtein V, Gordon HM, et al. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
22. Hollman PC, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol. 1999;37:937-942.
23. Haider UG, Sorescu D, Griendling KK, et al. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol. 2002;62:772-777.
24. Yoshizumi M, Tsuchiya K, Suzaki Y, et al. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun. 2002;293: 1458-1465.
25. Tijburg LB, Wiseman SA, Meijer GW, et al. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis. 1997;135:37-47.
26. Ahn HY, Hadizadeh KR, Seul C, et al. Epigallocatechin-3 gallate selectively inhibits the PDGF-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A 172). Mol Biol Cell. 1999;10:1093-1104.
27. Hwang KC, Lee KH, Jang Y, et al. Epigallocatechin-3-gallate inhibits basic fibroblast growth factor-induced intracellular signaling transduction pathway in rat aortic smooth muscle cells. J Cardiovasc Pharmacol. 2002;39:271-277.
28. Chen NY, Ma WY, Yang CS, et al. Inhibition of arsenite-induced apoptosis and AP-1 activity by epigallocatechin-3-gallate and theaflavins. J Environ Pathol Toxicol Oncol. 2000;19:287-295.
29. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483-16486.
30. Takeuchi K, Nakamura N, Cook NS, et al. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem Biophys Res Commun. 1990;172: 1199-1194.
31. Claret FX, Hibi M, Dhut S, et al. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature. 1996; 383:453-457.
32. Dorsey MJ, Tae HJ, Sollenberger KG, et al. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene. 1995;11:2255-2265.
33. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997;9:240-246.
34. Cruzalegui FH, Hardingham GE, Bading H. c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation. EMBO J. 1999;18:1335-1344.
35. Kukushkin AN, Abramova MV, Svetlikova SB, et al. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Oncogene. 2002;21:719-730.
36. Ingram AJ, Ly H, Thai K, et al. Mesangial cell signaling cascades in response to mechanical strain and glucose. Kidney Int. 1999;56:1721-1728.
37. Yang GY, Liao J, Li C, et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and nontransformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis. 2000;21: 2035-2039.
38. Higashita R, Li L, Van Putten V, et al. Galpha16 mimics vasoconstrictor action to induce smooth muscle alpha-actin in vascular smooth muscle cells through a Jun-NH2-terminal kinase-dependent pathway. J Biol Chem. 1997;272:25845-25850.
39. Dimmeler S, Zeiher AM. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept. 2000;90:19-25.
40. Nakagawa T, Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol. 2002;40:1745-1750.
41. Salah N, Miller NJ, Paganga G, et al. Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys. 1995;322:339-346.